2092 Updated analysis: Observational cohort study of 1st line bevacizumab combined with chemotherapy in metastatic colorectal cancer (HGCSG0802): Comparison of infusional FU/oxaliplatin(OX)+BV and oral FU/OX+BV. (September 2015) - Nakatsumi, H.; Yuki, S.; Kawamoto, Y.; Muranaka, T.; Hatanaka, K.; Kato, T.; Meguro, T.; Nakamura, M.; Iwanaga, I.; Uebayashi, M.; Tateyama, M.; Eto, K.; et al.